Effects of Kinesio Taping Techniques in COPD Patients

October 31, 2022 updated by: Burcu Camcıoğlu Yılmaz, Muğla Sıtkı Koçman University

Effects of Kinesio Taping Techniques on Pulmonary Parameters and Functional Exercise Capacity in Patients With Chronic Obstructive Pulmonary Disease

Study will investigate effects of two different kinesio taping techniques on pulmonary parameters of patients with COPD.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Chronic Obstructive Pulmonary Disease (COPD) is an irreversible, progressive, treatable airway disease which causes dyspnea, wheezing, coughing and increased secretions in airways. Thoracic and respiratory mechanics are impaired, respiratory muscle strength and functional exercise capacity is decreased in patients with COPD. As a result dyspnea, limitation in activities of daily living, postural impairments, muscle length-strength relationship changes and increased mechanical loads on respiratory muscles occur. In literature it has been demonstrated that Kinesio Taping have therapeutic effects on respiratory functions and functional exercise capacity in patients with chronic neurological diseases who has additional respiratory impairments. Although there are several studies in literature investigating the effects of facilitation and inhibition taping techniques applied on respiratory muscles in patients with COPD, effects of thoracic and postural mechanical correction techniques as an alternative treatment modality in patients with COPD have not been investigated yet. In present study, effects of thoracic mechanical correction and facilitation taping techniques in patients with COPD will be investigated, and data will be collected for effects of thoracic mechanical correction taping on pulmonary parameters in patients with COPD.

Study Type

Interventional

Enrollment (Actual)

43

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
    • Menteşe
      • Muğla, Menteşe, Turkey, 48000
        • Mugla Sıtkı Kocman University Training and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

38 years to 78 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Male and female COPD patients aged between 40-80 years
  • Diagnosed with COPD stage I-II-III-IV according to GOLD 2019 criterias
  • Able to speak, understand and read Turkish language
  • Volunteering to participate in study

Exclusion Criteria:

  • Unstable or acutely exacerbated patients with COPD
  • Alterations in medical treatment in last 6 months
  • Having comorbidities that affect directly cardiopulmonary system, uncontrolled arterial hypertension, severe congestive heart failure, coronary arterial disease, heart valve disease
  • Orthopaedic, neurological, psychiatric disease, peripheral/central nervous system diseases, mental retardation, antidepressants usage, metabolic impairments, malignancy
  • Unable to cooperate for measurement and treatment techniques used in study
  • Irritation, infection, allergic reaction, scarred burn or open wound around application area
  • Enrolled in a comprehensive pulmonary rehabilitation program before study
  • Application of Kinesio Tape to any body region in the past
  • History of an open heart surgery or other thoracic surgeries

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Facilitation Tape
Diaphragm and Intercostal muscles will be taped with facilitation technique. After 30 minutes of application patients will be evaulated for pulmonary parameters, functional exercise capacity and dyspnea.
Device: Kinesio Taping
Kinesio Taping is a special taping method developed by Dr. Kenzo Kase in 1973. This technique triggers natural healing responses of human body by activating nervous and circulatory systems. The tapes are thin, latex-free, cotton, porous and anti-allergenic, with equal thickness of epidermis. It has elastic properites which allows the tape to elongate to %55-60 of its original lenght. Tape can be used up to 1 week even after sweating or cleaning with water. There are different application techniques for different purposes. Facilitation technique facilitates muscle contractions and supports muscle function. Mechancial correction technique is used for joint positioning and correcting motion of muscle-joint dynamics.
Active Comparator: Mechanical Correction Tape
Thorax will be taped with mechanical correction technique. After 30 minutes of application patients will be evaulated for pulmonary parameters, functional exercise capacity and dyspnea.
Device: Kinesio Taping
Kinesio Taping is a special taping method developed by Dr. Kenzo Kase in 1973. This technique triggers natural healing responses of human body by activating nervous and circulatory systems. The tapes are thin, latex-free, cotton, porous and anti-allergenic, with equal thickness of epidermis. It has elastic properites which allows the tape to elongate to %55-60 of its original lenght. Tape can be used up to 1 week even after sweating or cleaning with water. There are different application techniques for different purposes. Facilitation technique facilitates muscle contractions and supports muscle function. Mechancial correction technique is used for joint positioning and correcting motion of muscle-joint dynamics.
No Intervention: No Tape
Patients will be evaulated for pulmonary parameters, functional exercise capacity and dyspnea with no tape.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pulmonary Function Test
Time Frame: 30 minutes after every application
Pulmonary functions will be evaulated in laboratory conditions. Dynamic lung volumes will be measured using standardized spirometric measurement regulations established by ATS/ERS guidelines.
30 minutes after every application
Respiratory Muscle Strength
Time Frame: 30 minutes after every application
Respiratory muscle strenght will be measured as Maximum Inspiratory Pressure & Maximum Expiratory Pressure with MicroMPM device. Measuring procedure will be held according to ERS guidelines. Measurements will be interpreted with Black and Hyatt's references.
30 minutes after every application
Functional Exercise Capacity
Time Frame: 30 minutes after every application
Functional exercise capacity will be measured with 6-minute walk test. Cardiovascular paremeters, dyspnea, respiratory rate and fatigue will be evaulated before, during and after the test .
30 minutes after every application
Dyspnea
Time Frame: 30 minutes after each application
Dyspnea in daily living was evaluated by the Modified Medical Research Council Dyspnea Scale. The scale consists in five statements that describe almost the entire range of dyspnea from none (Grade 0) to almost complete incapacity (Grade 4). Higher scores indicates increased dyspnea perception.
30 minutes after each application

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perception of Disease
Time Frame: 30 minutes after each application.
COPD Assesment Test (CAT) will be used to evaulate patients perception of symptoms.
30 minutes after each application.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Muğla Sıtkı Koçman University

Investigators

  • Study Director: Burcu Camcıoğlu Yılmaz, PT, PhD, Muğla Sıtkı Koçman University
  • Principal Investigator: Metehan Sarıkaya, MSc. Student, Muğla Sıtkı Koçman University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 20, 2022

Primary Completion (Actual)

October 31, 2022

Study Completion (Actual)

October 31, 2022

Study Registration Dates

First Submitted

January 22, 2020

First Submitted That Met QC Criteria

January 22, 2020

First Posted (Actual)

January 27, 2020

Study Record Updates

Last Update Posted (Actual)

November 1, 2022

Last Update Submitted That Met QC Criteria

October 31, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • KPR1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Obstructive Pulmonary Disease

Clinical Trials on Kinesio Taping

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Austria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe